CrushSCI.com
提供学术论文选刊润色服务
npj Breast Cancer 期刊封面 医学
返回期刊列表

Review Cycle Records

npj Breast Cancer

Springer SCIE OA
2026新锐 2区2025中科院 2区 TOP2025 JCR Q1
123.2平均天数
119.5中位天数
46最短天数
218最长天数
1672025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

132 天

Proteomic signatures identify significantly different inflammatory breast tissue microenvironments depending on mammographic density or estrogen exposure

作者Menikae K. Heenkenda; Annelie Abrahamsson; Peter Lundberg; Charlotta Dabrosin

作者单位1. Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; 2. Clinical Department of Oncology, Region Östergötland, Linköping, Sweden; 3. Clinical Department of Medical Radiation Physics, Region Östergötland, Linköping, Sweden; 4. Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden; 5. Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden; 6. Clinical Department of Radiology, Region Östergötland, Linköping, Sweden

PDF源文件 DOI 网页
218 天

Genomic characterization of ER-positive primary tumors and corresponding relapses identifies potentially targetable alterations

作者Caroline Schagerholm Stanev; Stephanie Robertson; Hosein Toosi; Emmanouil G. Sifakis; Jens Lagergren; Johan Hartman

作者单位1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Division of Computational Science and Technology, KTH Royal Institute of Technology and Science for Life Laboratory, Stockholm, Sweden; 3. Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden

PDF源文件 DOI 网页
207 天

DynamicBUS: restoring temporal dynamics from static ultrasound for improved breast cancer diagnosis

作者Zhikai Yang; Yaofang Liu; Tianhao Bai; Ander Biguri; Haoyuan Chen; Yonghao Li; Carola-Bibiane Schönlieb; Örjan Smedby; Raymond Chan; Rodrigo Moreno

作者单位1. Department of Biomedical Engineering and Health Systems, KTH Royal Institute of Technology, Stockholm, Sweden; 2. City University of Hong Kong, Hong Kong, China; 3. COCHE, Hong Kong, China; 4. Department of Ultrasound, Aviation General Hospital, Beijing, China; 5. University of Cambridge, Cambridge, UK; 6. School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, China; 7. Lingnan University, Hong Kong, China; 8. Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden

PDF源文件 DOI 网页
113 天

Genome-wide DNA methylation profiling of triple-negative breast cancer uncovers epigenetic biomarkers of tumor identity and the immune microenvironment

作者Iñaki Sasiain; Deborah F. Nacer; Mats Jönsson; Johan Vallon-Christersson; Anita Grigoriadis; Mattias Aine; Johan Staaf

作者单位1. Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden; 2. Lund University Cancer Center, Lund University, Lund, Sweden; 3. Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; 4. Cancer Bioinformatics, Breast Cancer Now Unit, Comprehensive Cancer Centre, Faculty of Life Sciences and Medicine, King’s College London, London, UK; 5. Spatial Biology Facility, Faculty of Life Sciences and Medicine, King’s College London, London, UK

PDF源文件 DOI 网页
96 天

Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control

作者Gai Liang; Qu Zhang; Mengting Yuan; Guojun Yao; Feng Yuan

作者单位1. Department of Radiation Oncology, Hubei Cancer Hospital, TongJi Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, National Key Clinical Specialty, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan Clinical Research Center for Breast Cancer, Wuhan, China

PDF源文件 DOI 网页
46 天

Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factors

作者B. Aldrige Allister; Winfried Hofmann; Jonathan L. Lühmann; Björn Sander; Lena Wendeburg; Gunnar Schmidt; Bernd Auber; Susanne Morlot; Hannah Wallaschek; Nataliya di Donato; Brigitte Schlegelberger; Monika M. Golas; Doris Steinemann

作者单位1. Department of Human Genetics, Hannover Medical School, Hannover, Germany; 2. Institute of Pathology, Hannover Medical School, Hannover, Germany; 3. Institute of Human Genetics, University Hospital Augsburg and Faculty of Medicine, University of Augsburg, Augsburg, Germany; 4. Comprehensive Cancer Center Augsburg, University Hospital Augsburg, Augsburg, Germany

PDF源文件 DOI 网页
155 天

Novel method for risk stratification of radiation-induced breast fibrosis: subgroup hypothesis verified by machine learning

作者Ahmad Sami; Petra Seibold; Carsten Sticht; Frank A. Giordano; Marlon R. Veldwijk; Carsten Herskind

作者单位1. Cellular and Molecular Radiation Oncology Lab, Dept. of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 2. DKFZ Hector Cancer Institute at University Medicine Mannheim, Heidelberg, Germany; 3. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 4. Core Facility Platform Mannheim (CFPM), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 5. Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 6. Mannheim Institute of Intelligent Systems in Medicine (MIISM), Heidelberg University, Mannheim, Germany

PDF源文件 DOI 网页
57 天

SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer

作者François-Clement Bidard; Carlos Barrios; Giampaolo Bianchini; Adam M. Brufsky; Stephen Chia; Javier Cortes; Massimo Cristofanilli; Giuseppe Curigliano; Shaheenah Dawood; Peter A. Fasching; Lorenzo Gerratana; Antonio Giordano; Michail Ignatiadis; Hiroji Iwata; Wolfgang Janni; Elgene Lim; Kevin Kalinsky; Cynthia X. Ma; Erica L. Mayer; Arielle J. Medford; Jason A. Mouabbi; Joyce O’Shaughnessy; Yeon Hee Park; Javier Pascual; Pedram Razavi; Sarah Sammons; José Luis Sandoval; Luisana Sisca; Paolo Tarantino; Seth A. Wander; Gustavo Werutsky; Nicholas A. Turner

作者单位1. Department of Medical Oncology, Inserm CIC 2501, Institut Curie, Paris, France; 2. UVSQ, Universite Paris-Saclay, Paris, France; 3. Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; 4. Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; 5. School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy; 6. UPMC Magee-Womens Hospital, Pittsburgh, USA; 7. Division of Malignant Hematology/Medical Oncology, Department of Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA; 8. BC Cancer – Vancouver Cancer Centre, Vancouver, Canada; 9. International Breast Cancer Center (IBCC), Pangaea Oncology, Quirón Group, Barcelona, Spain; 10. IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid, Spain; 11. Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain; 12. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, Ridgewood, USA; 13. Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA; 14. Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; 15. Istituto Europeo di Oncologia, IRCCS, Milano, Italy; 16. Mediclinic Hospital, Dubai, United Arab Emirates; 17. Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates; 18. Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany; 19. Department of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Aviano, Italy; 20. Department of Medicine, University of Udine, Udine, Italy; 21. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 22. Harvard Medical School, Boston, USA; 23. Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B.), Université libre de Bruxelles (ULB), Brussels, Belgium; 24. Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan; 25. Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm, Germany; 26. Garvan Institute of Medical Research, Darlinghurst, Australia; 27. Faculty of Medicine, St Vincent’s Clinical School, UNSW Sydney, Darlinghurst, Australia; 28. St Vincent’s Hospital, Darlinghurst, Australia; 29. Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, USA; 30. Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, USA; 31. Mass General Cancer Center, Boston, USA; 32. Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; 33. Baylor University Medical Center, Dallas, USA; 34. Texas Oncology, Dallas, USA; 35. Sarah Cannon Research Institute, Dallas, USA; 36. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 37. Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain; 38. GEICAM Spanish Breast Cancer Group, Madrid, Spain; 39. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 40. Translational Oncology Partnership Program, Memorial Sloan Kettering Cancer Center, New York, USA; 41. Dana-Farber Brigham Cancer Center, Boston, USA; 42. Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 43. Dana-Farber Cancer Institute, Boston, USA; 44. Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; 45. Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy; 46. Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 47. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; 48. Department of Medical Oncology, Mass General Brigham Cancer Institute, Harvard Medical School, Boston, USA; 49. Royal Marsden NHS Foundation Trust, London, UK

PDF源文件 DOI 网页
82 天

The clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status

作者Kei Kawashima; Masanori Oshi; Akimitsu Yamada; Kazutaka Narui; Zunairah Shah; Thaer Khoury; Itaru Endo; Kazuaki Takabe

作者单位1. Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, USA; 2. Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan; 3. Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan; 4. Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA; 5. Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, USA; 6. Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, the State University of New York, Buffalo, USA; 7. Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; 8. Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan; 9. Department of Breast Surgery, Fukushima Medical University, Fukushima, Japan

PDF源文件 DOI 网页
126 天

Targeted axillary dissection in breast cancer patients: a systematic review and meta-analysis

作者Mohammed. N. Abdelaziz; Sagad O. O. Mohamed; Mohammed Hesham Nagi; Ibrahim Saleh Alawadi; Youstina Mohsen; Sohaila Essam Ibrahim; Radwa M. Abdelsattar; Asmaa. N. Abdelaziz; Mohamed Yasser; Sherif Wael; Hend A. Abdelgawad; Magdy Shehab; Khaled M. Abdelwahab; Omar Hamdy

作者单位1. Faculty of Medicine, Mansoura University Hospital, Mansoura, Egypt; 2. University of Khartoum, Khartoum, Sudan; 3. Faculty of medicine, Kasr Alainy, Cairo University, Cairo, Egypt; 4. Surgical Oncology Department, Oncology Centre, Mansoura University, Mansoura, Egypt

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。